Non-Drug, Non-Invasive, FDA-Cleared Device to Treat OCD

Brainsway, the medical device company that developed deep TMS, has been conducting clinical trials of the treatment in various psychiatric, neurological, and addiction disorders. Their most recent research suggests that deep TMS is an effective treatment for OCD. Christopher Von Jako, president and chief executive officer of Brainsway, joins Cheddar News to discuss.
More Videos
Best of CES 2026: Rise of the Robots!
From autonomous bots keeping airports running to humanoids that might become your best friend, take an exclusive look at the machines redefining how we live
Load More